Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

9.60
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
7.00
Today|||52-Week Range
17.20
+17.79%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close9.60
Today’s open8.90
Day’s range8.80 - 9.60
Volume420,697
Average volume (3 months)677,490
Market cap$517.3M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-715.02%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...0.000.00%
AKAOAchaogen Inc0.000.00%
RETAReata Pharmaceutical...0.000.00%
AKBAAkebia Therapeutics ...0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts